Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program, GO2 for Lung Cancer People with lung cancer receiving treatment may encounter acquired drug resistance—a reduction in treatment effectiveness over time. Tagrisso (osimertinib) is currently a frontline treatment for people [...]
Authors: Amy Kampschroeder MA, OTR/L, CHES, Manager, Patient Outreach and Special Initiatives and Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program In 2021, one of GO2 for Lung Cancer’s priorities continued to be bringing lung cancer education and empowerment to patients to help [...]
When you hear the doctor say the words “small cell lung cancer,” life suddenly changes. You may feel overwhelmed and grieved, lost or angry, or you may feel nothing at all. It is okay to move through all kinds [...]
Author: Jennifer C. King, PhD, Chief Scientific Officer, GO2 for Lung Cancer The World Conference on Lung Cancer features research on all types of thoracic cancers—and small cell lung cancer is no exception. There were many talks on new [...]
Don’t miss our deep dive on topics presented at IASLC's 2021 World Conference on Lung Cancer, including presentations from our very own GO2 for Lung Cancer Science and Research Team. Subscribe to our Magnifying LeNS newsletter and look out [...]
By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung Cancer Unlocking the Biology of SCLC Patients with small cell lung cancer (SCLC) receive one-size-fits-all treatment because of limited knowledge about the biology of the disease. There are [...]
A lung cancer diagnosis can feel overwhelming, even confusing. And while every diagnosis is different, one thing is the same: if you or someone you love is faced with lung cancer, we’re here to help. GO2 for Lung Cancer [...]
Innovative effort aims to improve outcomes for historically underserved lung cancer patient community. SAN CARLOS, Calif. and WASHINGTON, D.C., May 11, 2021 – GO2 for Lung Cancer (GO2 for Lung Cancer) has launched a landmark initiative to identify the [...]
By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung Cancer 1. What is Small Cell Lung Cancer? Small cell lung cancer (SCLC) is a type of lung cancer named for the very small, oval shaped cancer cells [...]
By Daniel A. Saez, M.Sc., Treatment and Trials Navigator, GO2 for Lung Cancer Patients diagnosed with Small Cell Lung Cancer (SCLC) have new hope because of recent advances in early detection and treatment. To amplify this positive message, we [...]